Clinical TrialID 3533
Effect of Papaverine on Renal Artery Blood Flow Volume
NCT04162834
Kidney Cancer
Relationship Network
Interactive first-hop connections across herbs, ingredients, formulas, targets, diseases, symptoms, syndromes, evidence, and monographs.
Click a node to open it in a new tab
Trial: 1Ingredient: 1Links: 1
Arranging relationship network...
Record Fields
Scalar fields from the final clinical_trial record.
- Clinical Trial Id
- 3533
- Evidence Id
- 3533
- Core Evidence Id
- 3533
- Source Clinical Trial Id
- 3506
- Herb2 Clinical Trial Id
- HBCT003506
- Nct Id
- NCT04162834
- Title
- Effect of Papaverine on Renal Artery Blood Flow Volume
- Status
- Completed
- Phase
- Phase 4
- Study Result
- No
- Study Condition
- Kidney Cancer
- Study Type
- Interventional
- Study Design
- Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: OTHER
- Intervention
- DRUG: Papaverine|DRUG: Normal saline
- Intervention Allocation
- Randomized
- Intervention Model
- Parallel
- Intervention Mask
- Quadruple
- Intervention Purpose
- Other
- Gender
- All
- Age
- Adult, Older_Adult
- Enrollment
- 96
- Outcome Measure
- Renal artery blood flow, Renal artery blood flow 2 minutes after papaverine administration by doppler sonography, at 2 minutes after papaverine administration
- Sponsor Collaborator
- Asan Medical Center
- Funded By
- OTHER
- Location
- Asan medical Center, Seoul, 05505, Korea, Republic of
- Other Id
- 20191111
- Start Date
- 2019-11-21
- Primary Completion Date
- 2021-04-15
- Completion Date
- 2021-04-15
- First Posted
- 2019-11-14
- Results First Posted
- Last Update Posted
- 2021-04-19
- Study Document
- Study Url
- https://clinicaltrials.gov/study/NCT04162834
- Title Cn
- Title En
- Effect of Papaverine on Renal Artery Blood Flow Volume
- Bilingual Status
- semi_complete